The spectrum of gut microbiome composition is readily but controversially distilled into a handful of community types. In this issue of Cell Host & Microbe, Lee et al. (2021) find that matching pre-existing community types (and associated molecular biomarkers) to the class of immune biologic therapy in inflammatory bowel disease may double the treatment response.

中文翻译：

---

幸福的家庭

肠道微生物组组成的范围很容易但有争议地被提炼为少数群落类型。在本期Cell Host & Microbe 中，Lee 等人。(2021) 发现将预先存在的社区类型（和相关的分子生物标志物）与炎症性肠病的免疫生物治疗类别相匹配可能会使治疗反应加倍。